<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
STIM
Neuronetics
$
()


  • Neuronetics announces publication of findings in Brain Stimulation

    4/10/2024 - 08:42am
  • NeuroStar Advanced Therapy receives FDA clearance

    3/25/2024 - 08:51am
  • Neuronetics announces 5-year exclusive partnership with TCN

    3/7/2024 - 08:23am
  • Neuronetics price target raised by $1 at Piper Sandler, here's why

    3/6/2024 - 07:22am
  • Neuronetics reports Q4 EPS (19c), consensus (26c)

    3/5/2024 - 07:41am
  • Neuronetics announces enhancements to TrakStar Patient Data Management System

    2/12/2024 - 08:34am
  • Neuronetics TMS patient access expands through Lucet Health policy update

    2/6/2024 - 08:29am
  • Neuronetics sees 2023 revenue over $71M, consensus $70.77M.

    1/8/2024 - 08:48am
  • Neuronetics sees Q4 revenue over $20M, consensus $19.76M

    1/8/2024 - 08:47am
  • Neuronetics receives 510(k) clearance for NeuroSite Coil Placement Accessory

    12/18/2023 - 08:50am
  • Neuronetics's NeuroStar TMS receives expanded regulatory approval in Japan

    12/4/2023 - 08:58am
  • Neuronetics upgrades software solutions for depression treatment

    11/13/2023 - 09:03am
  • Neuronetics announces momentum from health plans for TMS therapy coverage

    11/9/2023 - 08:43am
  • Neuronetics price target lowered to $7 from $12 at JMP Securities

    11/8/2023 - 09:21am
  • Neuronetics sees Q4 revenue $19M-$21M, consensus $19.76M

    11/7/2023 - 07:37am
dynamic_feed Breaking News